Latest 10-K annual reports

Longduoduo Company Limited reported a significant 42% decrease in total revenue for the fiscal year ended June 30, 2025, primarily due to reduced principal sales and economic environment impacts.

TriUnity Business Services Limited reported increased revenue for fiscal year 2025 but faces substantial doubt about its ability to continue as a going concern due to rising losses and internal control deficiencies.

Astrotech Corporation reported a significant increase in net loss and a substantial decrease in revenue for fiscal year 2025, despite progress in product commercialization and new subsidiary launches.

LightPath Technologies reports 17% revenue growth in fiscal year 2025, driven by strategic acquisitions and a shift towards higher-margin infrared imaging systems, despite continued net losses.

Defense Technologies International Corp. reported zero revenue and increased net losses for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.

Woodbridge Liquidation Trust extends its estimated termination date to February 2027, citing ongoing litigation over a $60 million construction defect claim and suspending further distributions.

Paramount Gold Nevada Corp. reported a net loss of $9.05 million for fiscal year 2025, while making significant progress on permitting for its Grassy Mountain Project and addressing going concern doubts.

Armlogi Holding Corp. reported a net loss of $15.3 million for fiscal year 2025, despite revenue growth, as increased operating costs and geopolitical trade tensions impacted profitability.

Legacy Education Inc. announced significant revenue and net income growth for fiscal year 2025, driven by increased student enrollment and strategic acquisitions, despite a complex and evolving regulatory landscape.

Stitch Fix reported a significant reduction in net loss for fiscal year 2025, despite a continued decrease in active clients and overall revenue.

Tamboran Resources Corporation's latest 10-K details significant operational progress in the Beetaloo Basin, alongside substantial financial losses and ongoing capital requirements, raising going concern doubts.

Golden Star Resource Corp., an exploration-stage mining company, reported increased net losses for fiscal year 2025 and continues to face substantial doubt about its ability to continue as a going concern without significant new financing.

Rave Restaurant Group, Inc. reported increased net income and Adjusted EBITDA for fiscal year 2025, driven by Pizza Inn's growth despite a decline in Pie Five units and overall revenue.

Upexi, Inc. reported a significant net loss for fiscal year 2025 while strategically shifting its core business to a Solana-focused digital asset treasury and consumer product brand ownership.

THOR Industries reports a 4.6% net sales decrease in fiscal 2025, driven by softening demand in North American Motorized and European segments, alongside strategic operational adjustments and a new share repurchase authorization.

Uranium Energy Corp. significantly expanded its operational footprint and advanced key projects in Fiscal 2025, despite reporting a net loss amidst volatile uranium prices.

Nutanix, a hybrid multicloud computing leader, reported strong fiscal year 2025 results, achieving GAAP net income and significant growth in subscription revenue and free cash flow.

Nexalin Technology, Inc. filed an amendment to its annual report, correcting internal control disclosures and refiling financials that show increased revenue but also widening net losses and persistent going concern doubts.

Palatin Technologies reported a $17.3 million net loss for fiscal year 2025, faces delisting from NYSE American, but secured a significant collaboration with Boehringer Ingelheim and advanced multiple drug candidates.

Natural Alternatives International, Inc. reported a net loss of $13.575 million for fiscal year 2025 despite a 14% increase in net sales, driven by increased operational costs, a litigation settlement, and a significant deferred tax asset valuation allowance.

Aytu BioPharma licenses EXXUA for MDD and raises $16.6M to support commercialization.

Integrated BioPharma, Inc. reported an 8% increase in net sales and a significant rise in net income for the fiscal year ended June 30, 2025, driven by growth in both Contract Manufacturing and Other Business Lines segments.

InMed Pharmaceuticals Inc. reported its fiscal year 2025 results, highlighting progress in its Alzheimer's and dry AMD drug candidates, alongside revenue growth in its BayMedica segment, despite ongoing operating losses and a going concern doubt.

FONAR Corporation reported a decrease in net income for fiscal year 2025 to $10.7 million from $14.1 million in fiscal 2024, driven by higher operating costs and a significant credit loss reserve.

Benitec Biopharma Inc. restated prior period financial statements due to share-based compensation errors, while continuing to advance its lead OPMD gene therapy, BB-301, through clinical trials.

Cannabis Bioscience International Holdings, Inc. reported a reduced net loss for fiscal year 2025, driven by increased clinical trial revenue, while facing significant going concern doubts and a need for substantial capital.

GivBux Inc. reports significant revenue growth in 2024 driven by its Super App, but faces substantial net losses and a going concern doubt, highlighting critical funding needs.

HNO International, Inc. filed an amended annual report to correct service stock valuations, revealing increased stock-based compensation and a higher net loss for fiscal year 2024.

The Marygold Companies, Inc. reported an increased net loss of $5.8 million for fiscal year 2025, driven by reduced revenue in fund management and food products, despite decreased operating expenses.

B. Riley Financial reports a significant net loss of $774.9 million for 2024, driven by investment impairments, while actively reducing its total indebtedness through strategic asset dispositions.